NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010

from The NRG Oncology Podcast · host NRG Oncology

Our co-hosts interview NRG-HN009 PI Dr. Paul Harari on the recently reported initial results of NRG-HN009 at the 2026 Multidisciplary Head and Neck Cancer Symposium. Additionally, this episode discusses NRG-HN010 for HER2-expressing salivary gland cancer with Study PI, Dr. Alan Ho.

Episode metadata supplied by the publisher feed · Published Feb 20, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010

0:00 37:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 37 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on February 20, 2026.

Can I download this The NRG Oncology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!